BiomX Inc.

PHGE · NYSE · SIC 2836: Biological Products, (No Diagnostic Substances)
172
SEC Filings

Business Summary

PART I Overview We are a clinical stage product discovery company developing products using both natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases, such as diabetic foot infections, or DFI . Bacteriophage or phage are bacterial, species-specific, strain-limited viruses that infect, amplify and kill the target bacteria and are considered inert to mammalian cells. By utilizing proprietary combinations of naturally occur...

Next Earnings

Q2 FY2026 — expected 2026-08-18

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionPHGEdiscussed_in_filing Cybersecurity
topic_mentionPHGEdiscussed_in_filing Trusted Computing
topic_mentionPHGEdiscussed_in_filing Blockchain & Crypto
topic_mentionPHGEdiscussed_in_filing Regulation
topic_mentionPHGEdiscussed_in_filing Healthcare & Bio
topic_mentionPHGEdiscussed_in_filing AI Compute
topic_mentionPHGEdiscussed_in_filing Platform & Ecosystem
topic_mentionPHGEdiscussed_in_filing Sovereign & Government
topic_mentionPHGEdiscussed_in_filing Cybersecurity
topic_mentionPHGEdiscussed_in_filing Trusted Computing
topic_mentionPHGEdiscussed_in_filing Blockchain & Crypto
topic_mentionPHGEdiscussed_in_filing Regulation
topic_mentionPHGEdiscussed_in_filing Healthcare & Bio
topic_mentionPHGEdiscussed_in_filing AI Compute
topic_mentionPHGEdiscussed_in_filing Platform & Ecosystem
topic_mentionPHGEdiscussed_in_filing Sovereign & Government
topic_mentionPHGEdiscussed_in_filing Cybersecurity
topic_mentionPHGEdiscussed_in_filing Trusted Computing
topic_mentionPHGEdiscussed_in_filing Blockchain & Crypto
topic_mentionPHGEdiscussed_in_filing Regulation

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-192025-12-310001213900-26-018231EDGAR81K words
2025-03-252024-12-310001013762-25-002283EDGAR—
2024-04-042023-12-310001213900-24-030053EDGAR—
2023-03-292022-12-310001213900-23-024122EDGAR—
2022-03-302021-12-310001213900-22-016136EDGAR—
2021-03-312020-12-310001213900-21-019233EDGAR—
2020-03-262019-12-310001213900-20-007405EDGAR—
2019-08-212019-06-300001213900-19-016461EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001213900-25-109186EDGAR25K words
2025-08-132025-06-300001213900-25-075328EDGAR—
2025-05-152025-03-310001213900-25-044157EDGAR—
2024-11-142024-09-300001213900-24-098523EDGAR—
2024-08-142024-06-300001213900-24-068981EDGAR—
2024-05-202024-03-310001213900-24-045273EDGAR—
2023-11-142023-09-300001213900-23-086662EDGAR—
2023-08-092023-06-300001213900-23-064926EDGAR—
2023-05-152023-03-310001213900-23-039734EDGAR—
2022-11-092022-09-300001213900-22-070435EDGAR—
2022-08-102022-06-300001213900-22-046257EDGAR—
2022-05-112022-03-310001213900-22-025542EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-010001213900-26-038095EDGAR10K words
2026-03-270001213900-26-035605EDGAR—
2026-03-190001213900-26-031587EDGAR—
2026-03-110001213900-26-026174EDGAR—
2026-03-060001213900-26-024344EDGAR—
2026-03-020001213900-26-022301EDGAR—
2026-02-250001213900-26-020374EDGAR—
2026-02-130001213900-26-016402EDGAR—
2026-02-100001213900-26-014298EDGAR—
2026-01-140001213900-26-004348EDGAR—

172 total filings indexed. 142 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001739174
TickerPHGE
ExchangeNYSE
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b5dc463384468b6f89382678e6aa8404144d887412827d60d82552fd8706b089
parent: 9bd625768f31a50532cbb931040dcf1446733dc0dfe315893c2ce3be18ff5d56
content hash: 75a2ccbdaa6ab2641a014cfe23d4530f9928fbb61cb7b50287f456c185a03872
signed: 2026-04-13T04:46:53.734Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf